These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25425602)

  • 41. Treatment of Kawasaki disease.
    Newburger JW
    Lancet; 1996 Apr; 347(9009):1128. PubMed ID: 8609740
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term issues in Kawasaki disease.
    Gersony WM
    J Pediatr; 1992 Nov; 121(5 Pt 1):731-3. PubMed ID: 1432422
    [No Abstract]   [Full Text] [Related]  

  • 43. Kawasaki disease: etiopathogenesis and novel treatment strategies.
    Agarwal S; Agrawal DK
    Expert Rev Clin Immunol; 2017 Mar; 13(3):247-258. PubMed ID: 27590181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose aspirin in Kawasaki disease.
    Shulman ST
    J Pediatr; 1999 Apr; 134(4):523-4. PubMed ID: 10190936
    [No Abstract]   [Full Text] [Related]  

  • 45. Kawasaki Disease Shock Syndrome (KDSS)--Presentation of 3 Children and Review of the Literature.
    Camacho-Lovillo MS; Melón M; Moreno MD; Ardanuy AV; Neth O
    Klin Padiatr; 2015 Nov; 227(6-7):355-7. PubMed ID: 26356320
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical application of rapid assay of serum interleukin-6 in Kawasaki disease.
    Suganami Y; Kawashima H; Hasegawa D; Sato S; Hoshika A
    Pediatr Int; 2008 Apr; 50(2):264-6. PubMed ID: 18353077
    [No Abstract]   [Full Text] [Related]  

  • 47. The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.
    Leung DY
    Clin Rev Allergy; 1992; 10(1-2):93-104. PubMed ID: 1606527
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of plasma exchange therapy for Kawasaki disease by cytokine profiling.
    Kashiwagi Y; Kawashima H; Akamatsu N; Morishima Y; Nishimata S
    Ther Apher Dial; 2012 Jun; 16(3):281-3. PubMed ID: 22607573
    [No Abstract]   [Full Text] [Related]  

  • 49. Kawasaki disease in Nebraska: a review of the literature.
    Cheatham JP; Kugler JD; Pinsky WW; Hofschire PJ
    Nebr Med J; 1983 Sep; 68(9):282-93. PubMed ID: 6355872
    [No Abstract]   [Full Text] [Related]  

  • 50. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z; Kawasaki T
    Drugs; 1999 Nov; 58(5):813-22. PubMed ID: 10595862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kawasaki disease.
    Sundel RP
    Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Complexities of the Diagnosis and Management of Kawasaki Disease.
    Rowley AH
    Infect Dis Clin North Am; 2015 Sep; 29(3):525-37. PubMed ID: 26154665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kawasaki syndrome.
    Rowley AH; Gonzalez-Crussi F; Shulman ST
    Curr Probl Pediatr; 1991 Oct; 21(9):387-405. PubMed ID: 1743048
    [No Abstract]   [Full Text] [Related]  

  • 55. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yoshida S; Sakurai Y; Takeda T; Fukuda K
    J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975
    [No Abstract]   [Full Text] [Related]  

  • 56. Kawasaki disease.
    Narayanan SN; Krishnaveni ; Sabarinathan K
    Indian Pediatr; 1997 Feb; 34(2):139-43. PubMed ID: 9255010
    [No Abstract]   [Full Text] [Related]  

  • 57. Kawasaki disease resistant to immunoglobulin G therapy.
    Venugopalan P; Jaya S; Al-Azri MA; Piopongco E
    Ann Trop Paediatr; 2003 Sep; 23(3):187-91. PubMed ID: 14567834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kawasaki Disease.
    Selmek K; Harding M
    Pediatr Rev; 2024 Jul; 45(7):425-427. PubMed ID: 38945984
    [No Abstract]   [Full Text] [Related]  

  • 59. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
    Leung DY
    Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kawasaki disease after all.
    Rodríguez-González M; Gámez-González LB; Garrido-García M; Yamazaki-Nakashimada MA
    Semin Arthritis Rheum; 2016 Jun; 45(6):e24. PubMed ID: 26639032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.